About Prof. Dr. Melanie Meyer-Luehmann
Prof. Dr. Melanie Meyer-Luehmann is a Full Professor of Functional Restoration in the CNS (W3) and Head of the Neurodegeneration Research Group, Department of Neurology and Neurophysiology, at the Medical Center — University of Freiburg, Germany, with 20+ years of neuroscience and neurodegeneration research experience. She completed her M.S. (Diplom) in Biology at the University of Freiburg (2000), her PhD in Neurobiology (summa cum laude) at the University of Basel, Switzerland (2004), and completed postdoctoral fellowship at Harvard Medical School, Boston, USA (2005–2008). She was awarded the Emmy Noether Career Development Grant from the Deutsche Forschungsgemeinschaft (DFG, 2009) — a highly competitive German research excellence award.
- Full Professor (W3) of Functional Restoration in CNS — Medical Center, University of Freiburg since 2011; Emmy Noether Career Development Grant (DFG, 2009)
- M.S. (Diplom) — University of Freiburg (2000); PhD (summa cum laude) — University of Basel (2004); Postdoctoral Fellow — Harvard Medical School, Boston, USA (2005–2008)
- Research: Alzheimer's disease pathomechanisms (amyloid-beta plaques, seeding), neuroinflammation, microglia in neurodegeneration, adult neurogenesis
- Member — SFB 596 'Molecular Mechanisms of Neurodegeneration' (since 2009); Member — Society for Neuroscience
- High-impact publications including Nature (2008), Science (2006), Nature Neuroscience (2003)
Qualifications & Credentials
Academic Degrees
- Graduate Studies in Biology — University of Freiburg, Germany — 1993–1999
- M.S. (Diplom) in Biology — University of Freiburg, Germany — 2000 (Thesis also at University of Michigan, Ann Arbor, USA with Prof. John Wayne Aldridge)
- PhD in Neurobiology (summa cum laude) — University of Basel, Switzerland — 2000–2004 (with Prof. Mathias Jucker; Thesis: Experimental approaches to study cerebral amyloidosis in Alzheimer's disease)
Fellowships & Special Training
- Postdoctoral Fellow — Hertie Institute of Clinical Brain Research, Tübingen, Germany (with Prof. Mathias Jucker) — 2004–2005
- Postdoctoral Fellow — Massachusetts General Institute for Neurodegenerative Disease (MIND), Harvard Medical School, Boston, USA (with Prof. Bradley T. Hyman) — 2005–2008
- Independent Research Group Leader — Adolf-Butenandt-Institut, Ludwig-Maximilians-University (LMU) Munich — 2008–2011
Certifications & Accreditations
- Full Professor (W3) of Functional Restoration in CNS — Medical Center, University of Freiburg (since 2011)
- Member — SFB 596 'Molecular Mechanisms of Neurodegeneration' (since 2009)
- Member — Society for Neuroscience
- Reviewer — Major international neuroscience and neurology journals
Areas of Expertise
Major Research & Clinical Areas
- Alzheimer's Disease (Amyloid-Beta Plaque Formation & Seeding)
- Neurodegeneration & Dementia
- Neuroinflammation (Microglia in Neurodegeneration)
- Adult Neurogenesis in Alzheimer's Disease
- White Matter Integrity in Neurodegeneration
- Cerebral Amyloidosis
- Synaptic Dysfunction & Neuronal Loss
Sub-specialties
- Alzheimer's Disease Pathomechanisms (World-Leading Research): Prof. Meyer-Luehmann's landmark Nature publication (2008) — 'Rapid appearance and local toxicity of amyloid-beta plaques' — is among the most-cited works in Alzheimer's research worldwide. Her Science (2006) publication on exogenous induction of cerebral beta-amyloidogenesis established foundational knowledge of Alzheimer's seeding mechanisms — making her one of the world's foremost Alzheimer's disease researchers at Freiburg University Medical Center.
- Microglia & Neuroinflammation: Expert in the role of microglia (brain immune cells) in regulating adult neurogenesis and contributing to Alzheimer's disease pathogenesis — including microglial propagation of amyloid-beta and neuroinflammatory mechanisms.
- Functional CNS Restoration: Clinical and translational research focus on functional restoration in the CNS — including strategies to preserve or restore neurological function in Alzheimer's disease and other neurodegenerative conditions.
Advanced Procedures & Treatments (Clinical)
- Comprehensive Dementia Assessment & Diagnosis
- Cognitive Neurology Consultation
- Alzheimer's Disease — Diagnosis & Management
- Memory Clinic Consultations
- Advanced Neuroimaging (MRI, PET amyloid scanning)
- Clinical Trial Participation (Alzheimer's Disease Therapies)
Professional Experience
Current Affiliation
- Medical Center – University of Freiburg, Department of Neurology and Neurophysiology (Clinic for Neurology) — Full Professor (W3) & Head of Neurodegeneration Research Group (since 2011)
Past Affiliations
- Adolf-Butenandt-Institut, Ludwig-Maximilians-University (LMU) Munich — Independent Research Group Leader — 2008–2011
- Massachusetts General Institute for Neurodegenerative Disease (MIND), Harvard Medical School, Boston, USA — Postdoctoral Fellow — 2005–2008
- Hertie Institute of Clinical Brain Research, Tübingen, Germany — Postdoctoral Fellow — 2004–2005
- University of Basel, Switzerland — PhD Training — 2000–2004
Key Achievements
- Emmy Noether Career Development Grant — Deutsche Forschungsgemeinschaft (DFG) — 2009 (highly competitive German research excellence award)
- PhD (summa cum laude) — University of Basel — 2004
- Postdoctoral Fellow — Harvard Medical School, Boston, USA — 2005–2008
- Full Professor (W3) of Functional Restoration in CNS — Medical Center, University of Freiburg — since 2011
- Landmark publications in Nature (2008) and Science (2006) on Alzheimer's disease pathomechanisms
Awards & Recognitions
National & International Awards
- Emmy Noether Career Development Grant — Deutsche Forschungsgemeinschaft (DFG) — 2009
Professional Memberships
- SFB 596 'Molecular Mechanisms of Neurodegeneration' — Member (since 2009)
- Society for Neuroscience
Research & Publications
Published Papers (Selected)
- Meyer-Luehmann M, Spires-Jones TL, Prada C, et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature. 2008;451(7179):720-4.
- Meyer-Luehmann M, Coomaraswamy J, Bolmont T, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006;313(5794):1781-4.
- Meyer-Luehmann M, Stalder M, Herzig MC, et al. Extracellular amyloid formation and associated pathology in neural grafts. Nat Neurosci. 2003;6(4):370-7.
- Bachhuber T, Katzmarski N, McCarter JF, et al., Meyer-Luehmann M. Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med. 2015.
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Neurology / Dementia Consultation | €150 – €300 | $165 – $330 |
| Comprehensive Memory / Dementia Assessment | €500 – €1,500 | $550 – $1,650 |
| Advanced Neuroimaging (MRI + Cognitive Testing) | €1,000 – €3,000 | $1,100 – $3,300 |
| Second Opinion — Alzheimer's / Dementia | €200 – €500 | $220 – $550 |
| Clinical Trial Participation (Research Programme) | Contact hospital for details | Contact for details |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Prof. Dr. Melanie Meyer-Luehmann use in Neurology and Neurodegeneration treatment?
Prof. Dr. Meyer-Luehmann — Emmy Noether DFG Grant recipient, Harvard Medical School Postdoctoral Fellow, and author of landmark Nature and Science publications on Alzheimer's disease — uses advanced neuroimaging (MRI, PET amyloid scanning), comprehensive cognitive and memory assessment, and translational research protocols for Alzheimer's disease diagnosis and management at Medical Center – University of Freiburg, Germany.
2. What conditions does Prof. Dr. Melanie Meyer-Luehmann specialise in treating?
Prof. Dr. Meyer-Luehmann specialises in neurology and neurodegeneration — with world-leading expertise in Alzheimer's disease (amyloid-beta pathomechanisms), dementia, neuroinflammation, microglia in neurodegeneration, and functional CNS restoration — for patients seeking Alzheimer's disease diagnosis and management at Freiburg University Hospital, Germany.
3. How do I book an appointment with Prof. Dr. Melanie Meyer-Luehmann?
Appointments with Prof. Dr. Melanie Meyer-Luehmann can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Prof. Dr. Melanie Meyer-Luehmann?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Melanie Meyer-Luehmann, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Prof. Dr. Melanie Meyer-Luehmann offer second opinions for Neurology and Neurodegeneration cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients seeking expert Neurology and Neurodegeneration review from a specialist in Freiburg.









